Fair Lawn, NJ, United States of America

John M Werzel

This inventor holds 3 USPTO granted patents. Top assignee: H. Lundbeck A/s. Active years: 2006-2012.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: John M Werzel: Innovator in Pharmaceutical Composition

Introduction

John M Werzel is a notable inventor based in Fair Lawn, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mental health conditions such as depression and anxiety. With a total of 3 patents to his name, Werzel's work focuses on innovative therapeutic methods.

Latest Patents

One of his latest patents involves the use of GALR3 receptor antagonists for the treatment of depression and/or anxiety. This invention is directed to indolone derivatives that act as antagonists for the GALR3 receptor. The patent outlines a pharmaceutical composition that includes a therapeutically effective amount of a compound and a pharmaceutically acceptable carrier. Additionally, it describes a process for creating this pharmaceutical composition, ensuring that the methods are both effective and practical for therapeutic use.

Career Highlights

Werzel is currently associated with H. Lundbeck A/S, a company renowned for its focus on brain diseases. His work at Lundbeck has allowed him to explore and develop innovative solutions for mental health treatment, contributing to the advancement of pharmaceutical science.

Collaborations

Throughout his career, Werzel has collaborated with notable colleagues, including Michael J Konkel and Jamie Talisman. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic methods.

Conclusion

John M Werzel's contributions to the field of pharmaceuticals, particularly in the treatment of mental health disorders, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing therapeutic options for those in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…